Mechanism of the immunosuppressive effect in vivo of novel immunosuppressive drug beta-SQAG9, which inhibits the response of the CD62L+ T-cell subset.
Takenouchi M, Sahara H, Yamamoto Y, Matsumoto Y, Imai A, Fujita T, Tamura Y, Takahashi N, Gasa S, Matsumoto K, Ohta K, Sugawara F, Sakaguchi K, Jimbow K, Sato N.
Takenouchi M, et al. Among authors: matsumoto y, matsumoto k.
Transplant Proc. 2005 Jan-Feb;37(1):139-42. doi: 10.1016/j.transproceed.2004.12.204.
Transplant Proc. 2005.
PMID: 15808574